MarketPulse — Real-Time Financial News & Market Analysis

S&P 500 down 4.95%, Nasdaq down 6.86% year-to-date through March 2026. Historically, bull markets outlast bear markets; S&P 500 returned 343% since 2000 despite multiple crises.

Rising oil prices from Middle East tensions ripple beyond energy sector, pressuring travel, logistics, and consumer goods companies to raise prices.

Bitcoin declined to $68,951 amid geopolitical tensions, while Pepeto raised $8.28M and approaches Binance listing. Institutional accumulation continues.

Nissay Asset Management adopts Virtu Financial's Triton trading platform after launching domestic operations in September, with international expansion planned for 2026.

Pepeto launches Binance-level exchange as Ethereum crashes to $2,070 but spot ETFs see $157M daily inflows. Analysts target $7,500 ETH by 2026.

Rosen Law Firm seeks lead plaintiffs in securities lawsuit against Aquestive Therapeutics over alleged false statements regarding Anaphylm drug application.

$SNOW faces class action lawsuit over alleged misstatements on product efficiency, Iceberg Tables, and storage pricing. Stock fell 18% when revenue headwinds disclosed.

NuScale Power faces securities fraud lawsuit over alleged misstatements about ENTRA1 Energy partnership. Stock fell 14.4% after $495M payment disclosure; April 20, 2026 lead plaintiff deadline.

ServiceNow stock down 25% amid SaaS AI fears, but $NOW positioned as AI leader with Now Assist reaching $600M ACV, projected $1B by year-end.

Chevron emerges as better long-term investment over Occidental, offering diversified operations, stronger dividend history, and clearer growth visibility through 2030.

Pepeto launches ecosystem expansion with DeFi and AI features. Elon Musk's X Money crypto launch boosts Dogecoin 8%. Bitcoin stabilizes near $69,200 after recent volatility.

Pepeto launches AI-powered security upgrade for decentralized exchange. XRP targets $5-$10 as large holders join Pepeto presale ahead of rumored Binance listing.

Aldeyra Therapeutics stock plunged 71% after FDA rejected its reproxalap dry eye drug, prompting a securities investigation by Rosen Law Firm.

DNOW Inc. stock fell 19.1% following disappointing Q4 2025 results that missed expectations, triggering securities investigation and class action lawsuit.

Amazon plans $200B AI infrastructure spending in 2026—53% above analyst estimates—risking shareholder returns if deployment disappoints.

Beyond Meat relocates products from refrigerated to frozen sections at Walmart and Costco, signaling fading plant-based demand and ongoing profitability struggles.

Soleno Therapeutics faces class action lawsuit over alleged failure to disclose safety issues with drug DCCR, following 12-27% stock declines from August-September 2025 revelations.

Cameco positioned as key uranium supplier amid U.S. nuclear expansion plans, with 39% projected annual EPS growth through 2028 despite recent valuation concerns.

BofA MOVE Index surges 28% to 108.84, highest since April 2025, signaling potential stock market volatility amid geopolitical tensions and inflation concerns.

TRX Gold shares jump 42% YTD on record Tanzanian production and 40% revenue growth to $57.6M. Expansion plans and cost efficiency offer upside, but single-asset concentration poses risk.